1. Which of the statements concerning placement of the EZ-IO® Vascular Access System are correct? a) excessive pressure on driver during insertion b) Apply the EZ-Stablizer® Dressing after removal of the stylet c) The EZ-Connect® extension set should be primed d) Monitor the extremity/site frequently for signs of complications e) All of the above 2. For patients that respond to pain, consider using 2% lidocaine (preservative and epinephrine free) IO prior to initial flush. a) True b) False 3. Pain management for patients who are or responsive to pain may include regular periodic assessment for pain response AND PRN infusions of lidocaine following medical protocols. a) True b) False 4. The EZ-IO® Vascular Access System may be considered for use in the following situations/patients: a) Anytime vascular access is difficult b) When there is an urgent, emergent or medically necessary need for vascular access c) As a bridge to a central venous catheter or PICC placement d) All of the 5. Several studies and articles suggest the humerus may be a superior site for flow rates, drug delivery and management of infusion pain. a) True b) False 6. Which of the following is NOT a contraindication for use: a) Infection at the insertion site b) Recent fracture of the target bone c) Previous IO in target bone within 48 hours d) Presence of prosthesis or hardware at site e) Anticoagulant use by patient 7. You have inserted the needle set into the soft tissue and have not reached the bone, and cannot see a line on the needle remaining outside the patient’s skin. You should: stop and choose a longer needle length OR consider selecting a different IO site. a) True b) False 8. In the event of an emergency, product failure, or need for immediate assistance; clinicians should call the emergency phone number listed on the wristband or removal poster. a) True b) False
1. Which of the statements concerning placement of the EZ-IO® Vascular Access System are correct? a) excessive pressure on driver during insertion b) Apply the EZ-Stablizer® Dressing after removal of the stylet c) The EZ-Connect® extension set should be primed d) Monitor the extremity/site frequently for signs of complications e) All of the above 2. For patients that respond to pain, consider using 2% lidocaine (preservative and epinephrine free) IO prior to initial flush. a) True b) False 3. Pain management for patients who are or responsive to pain may include regular periodic assessment for pain response AND PRN infusions of lidocaine following medical protocols. a) True b) False 4. The EZ-IO® Vascular Access System may be considered for use in the following situations/patients: a) Anytime vascular access is difficult b) When there is an urgent, emergent or medically necessary need for vascular access c) As a bridge to a central venous catheter or PICC placement d) All of the 5. Several studies and articles suggest the humerus may be a superior site for flow rates, drug delivery and management of infusion pain. a) True b) False 6. Which of the following is NOT a contraindication for use: a) Infection at the insertion site b) Recent fracture of the target bone c) Previous IO in target bone within 48 hours d) Presence of prosthesis or hardware at site e) Anticoagulant use by patient 7. You have inserted the needle set into the soft tissue and have not reached the bone, and cannot see a line on the needle remaining outside the patient’s skin. You should: stop and choose a longer needle length OR consider selecting a different IO site. a) True b) False 8. In the event of an emergency, product failure, or need for immediate assistance; clinicians should call the emergency phone number listed on the wristband or removal poster. a) True b) False
VA_IOS_ClinicalPrinciplesExam_WM_MC-000540KEY.docx